December 01, 2010 article Open access Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer New England Journal of Medicine DOI: 10.1056/nejmoa0910320 Full text (OA) OpenAlex Authors 0 Author list not loaded yet. Cited by 1 stored of 212 Search Sort Most cited Newest Oldest Patent citations Title Any typearticle review book-chapter conference-paper preprint dissertation book dataset other Any fieldAgricultural and Biological Sciences Arts and Humanities Biochemistry, Genetics and Molecular Biology Business, Management and Accounting Chemical Engineering Chemistry Computer Science Decision Sciences Dentistry Earth and Planetary Sciences Economics, Econometrics and Finance Energy Engineering Environmental Science Health Professions Immunology and Microbiology Materials Science Mathematics Medicine Neuroscience Nursing Pharmacology, Toxicology and Pharmaceutics Physics and Astronomy Psychology Social Sciences Veterinary Open access Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) 2024 ESMO Open article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access 6 citations 1 result References 0